Intellectual Property India Publishes Patent Application for Ras Inhibitors And Methods Of Use Thereof

MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617055749 A) filed by Kestrel Therapeutics Inc. on May 01, 2026, for Ras Inhibitors And Methods Of Use Thereof.

Inventors include Ahmad, Omar K.; Fernando, Dilinie P.; Lajkiewicz, Neil; and Im, G-Yoon.

The application for the patent was published on June 05, 2026, under issue no. 23/2026.

Abstract: The disclosure provides compounds, e.g., compounds of Formula I, and their use in treating medical diseases or disorders, such as cancer. Pharmaceutical compositions and methods of making various indene compounds are provided. The compounds are contemplated to be modulators of Ras (e.g., K-Ras).

Disclaimer: Curated by HT Syndication.